After battling with AstraZeneca over shipment delays, and even casting doubt over its Covid-19 jab’s efficacy, EU countries are seeing stocks of the company’s shots pile up — unused.

As of Friday, France had administered 16 per cent of the 1.1m doses of the two-injection vaccine it received since the first delivery in early February, according to health ministry data. As of Thursday, Germany had given a little over one-fifth of the 1.45 million doses, about the same proportion as Italy, which has received over 1m doses. Spain has used just under a third of a total of 808,000 doses as of Friday.

The situation has prompted several European leaders to talk up the Oxford/AstraZeneca vaccine in recent days, with one French health ministry official even calling for a “collective rehabilitation campaign” to improve its reputation.